L&T Technology Services, Exponential-e Partner to Jointly Offer ‘New Normal’ Workplace Transformation Solutions
Exponential-e, a UK-based leading & innovative CSP of enterprise connectivity & unified communications services, today entered into a strategic partnership with L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a leading global pure-play engineering services company, to jointly offer workplace transformation solutions to customers working in the post-COVID environment.
In the “new normal” brought on by the pandemic, enterprises are ramping up operations in phases and planning to bring back their workforce, with their health and safety being the top priority. During these times, the need of the hour for companies is to retrofit the workplace with safety solutions on a fully digital foundation that can scale to intelligent buildings/campuses, smart facilities and offices.
According to the partnership, LTTS will offer its latest solution i-BEMS™ Shield, built on the company’s award-winning i-BEMS™ framework, and anchored on Exponential-e’s next-gen composite SDN carrier grade network & cloud infrastructure. The combination of these solutions will accelerate digital transformation of the workplace, across industries through digital technologies and platforms.
LTTS’ Intelligent Building Experience Management System, i-BEMS™ is a modular ‘system-of-systems’ platform that unifies all campus operations under one system and focuses on creating digital experiences and building optimization.
To build future-facing workplaces, i-BEMS™ is deploying Shield, a module within the solution that automates and develops smart systems and provides real-time insights to diagnose inefficiencies for quick decision making. i-BEMS™ Shield’s advanced digital interface redefines contactless interaction and surveillance by enabling temperature detection, face detection and tracking, air quality management, occupancy management and energy management.
Exponential-e, a leader in delivering fast, low latency connectivity, flexible and resilient Cloud solutions and world class IT services, will provide the platform for i-BEMS™ Shield to scale new heights of safety at workspace. The company’s ‘Software Defined-Digital Platform’, anchored on world class SD-WAN hosting the LTTS full stack digital innovation applications has the potential to spawn an ecosystem powered by digital VAS; drones-as-a service, connected cars, video-analytics as a service, AR/VR, gaming, smart cities & intelligent buildings are high in impact & value. Every industry is transforming itself through mobility & digital technologies. The LTTS-Exponential-e partnership accelerates the transformation by enabling a platform-based business federated in structure for companies across industries to collaborate and co-create new markets and revenue generating services.
Lee Wade, Founder & CEO, Exponential-e said, “The needs of businesses in the post-COVID environment is set for a dramatic change. While green quotient and sustainability were focus areas earlier for adopting smart building frameworks for campuses, enterprises now are faced with the urgent need of ensuring a safe and secured workplace environment for their workforces. With increasing customer engagement devices being used to help the modern-day work environment, we provide a software-defined network where functions can be deployed seamlessly. We are pleased to partner with an engineering services leader like LTTS and are confident that together, we will co-develop a value proposition that aligns with the present day needs of businesses in this ‘new normal’ world.”
Gaurav Gupta, Chief Business Officer, Europe, at L&T Technology Services said, “Worldwide the most evident trend to emerge as a fallout of COVID-19 are the disruptive innovations driven by new-age digital technologies. The role of ER&D services in shaping such cutting-edge innovative solutions will only grow. Our strategic partnership with Exponential-e is one such initiative that promises to redefine the smart building ecosystem and we are glad to be the pioneers on this front along with Exponential. This tie-up will lay the foundation for multiple industry leading initiatives on smart and secure workspaces and campuses in the near future.”
About L&T Technology Services Ltd
L&T Technology Services Limited (LTTS) is a publicly listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 53 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 16,600 employees spread across 17 global design centers, 28 global sales offices and 51 innovation labs as of June 30, 2020. For more information, visit https://www.ltts.com/
Exponential-e is a Cloud, Connectivity and Communications pioneer with a difference. From launching the world’s first Virtual private LAN in 2006 on its privately-owned 100GigE secure and super-fast Network, to its recent launch of its Software-Defined Digital Platform (SD-DP). (https://www.exponential-e.com/solutions/digital-transformation-model).
Exponential-e’s commitment to innovation has resulted in it being recognised as one of the fastest-growing private companies in the UK. Exponential-e has also built an extensive solutions portfolio, enabling the creation of services tailored specifically to its customers’ operational needs – whether that be for Private & Public Cloud, Data Centre, Unified Communications, Cyber Security or managed IT Services.
Delivering customer service excellence is at the heart of Exponential-e. That’s why it’s trusted by over 3,000 customers, with 96% reference-ability and an industry-leading Net Promoter Score of 73.
We work to international management standards and are accredited with 8 ISO accreditations. Today, Exponential-e employs 700 staff members across London, Manchester and Chippenham.
L&T Technology Services Limited
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Data from the APOLLO Study Show Clinically Meaningful Response with DARZALEX ® ▼ (daratumumab) Subcutaneous Formulation Regimen After First or Subsequent Relapse in Multiple Myeloma4.12.2020 20:52:00 CET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced results of the Phase 3 APOLLO study showing that the addition of DARZALEX®▼ (daratumumab) subcutaneous (SC) formulation to pomalidomide and dexamethasone (D-Pd) significantly reduced the risk of progression or death by 37 percent, compared to Pd alone in patients with multiple myeloma (MM) after the first or subsequent relapse of disease.1 The APOLLO results, which will be presented on Sunday, December 6 at 9:00 p.m. CET during the American Society of Hematology (ASH) 2020 Annual Meeting and featured in the ASH press briefing (Abstract #112), add to the body of evidence supporting treatment with daratumumab SC-based regimens for patients with relapsed MM. These data were the basis for recent regulatory submissions in Europe and the United States (U.S.) seeking approval for daratumumab SC in combination with Pd for the treatment of patients with relapsed or refractory MM, with two or more prior lines of therapy, includi
Citi Private Bank Issues Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World4.12.2020 17:36:00 CET | Press release
Citi Private Bank has released its Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World. The twice-yearly publication provides in-depth insights into the global economy and financial markets for the coming year and highlights multi-year “unstoppable trends” for client portfolios. This edition outlines why this is a remarkable time to be an investor. Just as the pandemic changed the price of every security when it arrived, the departure of COVID will mark the beginning of a new economic cycle, creating new opportunities for investors. Citi Private Bank expects 2021 will benefit from an economy that demonstrated resilience in the face of the worst global healthcare crisis in more than a century. 2020 was an opportunity for the world to “test drive the future” and make way for growth as the pandemic ebbs. The tailwinds for 2021 are underappreciated: our financial system is strong, government actions to protect individuals and businesses have been effective, technological
Takashi Nagao Appointed President and Chief Executive Officer of Medicago4.12.2020 17:00:00 CET | Press release
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, today announced Takashi Nagao as the company’s new President and Chief Executive Officer. Prior to becoming President and CEO, Mr. Nagao served as the Chairman of the Board of Medicago, where for the last four years, he has guided Medicago executives to get the company to where it is today. Medicago, a research and development company for the last 20 years, is embarking on a transformative year, one that will see the company build on its R&D roots to become a company that also produces and commercializes vaccines and other immunotherapies. Mr. Nagao has extensive experience leading pharmaceutical companies through the pre-commercial and commercial process and is well positioned to ensure the successful launch of Medicago’s COVID-19 and influenza vaccines, subject to regulatory approvals. Mr. Nagao will continue Medicago’s evolution towards its goal of being a fully operational commercial entity, able to respond
WorldRemit Leads the Way Offering a USD Payout Option in Nigeria4.12.2020 16:46:00 CET | Press release
WorldRemit, a leading digital cross-border payments business has announced that its customers in Nigeria can now receive remittances in foreign currency (USD) through its cash pick up providers. Following the announcement of the Central Bank of Nigeria (CBN) a day before, WorldRemit quickly adapted to the new requirements making it the first digital service to offer its customers worldwide the option of cash pickup in USD in Nigeria. WorldRemit enables Nigerians in over 50 countries around the world to support their family and friends in Nigeria. The decision by the Central Bank of Nigeria (CBN) to allow international money transfers to be paid in foreign currency, is aimed at providing increased liquidity in the foreign exchange market. The bank explained that the new regulation is part of its efforts to liberalize, simplify and improve the receipt and administration of diaspora remittances into Nigeria. Gbenga Okejimi, Country Manager, Nigeria and Ghana, at WorldRemit, said:“ We are
PPC Upgraded to ‘B’ with ‘Stable’ Outlook by S&P4.12.2020 15:16:00 CET | Press release
In its annual research update released on 27 November 2020, S&P upgraded PPC’s stand-alone credit profile (SACP) upward by two notches to ‘B’ from ‘CCC+’, resulting in an overall upgrade of the long-term credit rating of PPC to ‘B’ from ‘B-‘. According to S&P the two notch upgrade in PPC’s standalone corporate rating confirms that the Company’s strategic repositioning and the improved Greek energy market fundamentals have transformed its competitive position, reducing past concerns over its liquidity and long-term sustainability. The ‘Stable’ outlook underscores S&P’s expectation that PPC will continue to deliver on its transformation plan, with solid liquidity and improved margins. PPC’s strategic plan to convert its generation mix toward lower carbon dioxide (CO2) emissions improve its fleet competitiveness and long-term prospects. As mentioned in their report, S&P expects a substantial increase in EBITDA and improvement in credit metrics on the back of higher profitability as PPC ac
Chengdu Launches Online Exhibition of History and Culture to Enhance Cultural Ties With European Countries4.12.2020 13:17:00 CET | Press release
The launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition was held by the Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office on 24 November. The event, along with the unveiling ceremony of Chengdu Chronicles Culture Overseas (Europe) Exchange Cooperation, were witnessed by distinguished guests in many European countries including the Netherlands, Germany and Belgium through video and online connections. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201204005278/en/ On November 24, Gao Zhigang (center), Director of Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office, and other guests attend the launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition. (Photo: Business Wire) Chengdu History and Culture Overseas Virtual Exhibition will also be launched at major foreign media platforms for audiences all over the world. Gao ZhiGang, Director of Che
New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint4.12.2020 12:00:00 CET | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-620 (maribavir), in the treatment of transplant recipients with refractory/resistant cytomegalovirus (CMV) infection. The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e., one or a combination of ganciclovir, valganciclovir, foscarnet or cidofovir). The SOLSTICE trial met its primary endpoint, defined as the proportion of patients who achieved confirmed CMV viremia clearance compared to IAT at the end of Study week 8. In addition, the SOLSTICE trial met its key secondary endpoint, defined as achievement of CMV viremia clearance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom